Exelixis Reveals Preliminary Financial Outcomes for 2024 and Sets Ambitious Goals for 2025
January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
MORE NEWS
July 10, 2026 - 09:43
MindRank Announces $52 Million Series B FinancingMindRank AI Ltd., a clinical-stage biotechnology company based in Hangzhou, China, has announced the completion of a $52 million Series B financing round. The funding was led by a group of...
July 9, 2026 - 18:12
Trending: Salesforce stock dips on Keybanc downgrade, AstraZeneca drug trial falls shortShares of Salesforce moved lower on Thursday after Keybanc analysts downgraded the stock, citing concerns about slowing growth and a challenging enterprise spending environment. The downgrade from...
July 9, 2026 - 01:59
7 of world’s 10 biggest banks are now Chinese as Beijing’s financial aims growSeven of the world`s ten largest banks by assets are now Chinese, according to the latest ranking from The Banker magazine. China`s Big Four lenders -- Industrial and Commercial Bank of China,...
July 8, 2026 - 18:20
DLA Piper Picks Up Debt Finance Lawyer Teixeira in WashingtonDLA Piper has added Andre Teixeira as a partner in its project finance practice, based in the firm`s Washington office. The announcement was made Wednesday. Teixeira brings deep experience in debt...